BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 28470295)

  • 1. Hepcidin: a real-time biomarker of iron need.
    Hare DJ
    Metallomics; 2017 Jun; 9(6):606-618. PubMed ID: 28470295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of hepcidin in iron metabolism in inflammatory bowel diseases].
    Krawiec P; Pac-Kozuchowska E
    Postepy Hig Med Dosw (Online); 2014; 68():936-43. PubMed ID: 24988613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepcidin and iron disorders: new biology and clinical approaches.
    Arezes J; Nemeth E
    Int J Lab Hematol; 2015 May; 37 Suppl 1():92-8. PubMed ID: 25976966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepcidin: Homeostasis and Diseases Related to Iron Metabolism.
    Reichert CO; da Cunha J; Levy D; Maselli LMF; Bydlowski SP; Spada C
    Acta Haematol; 2017; 137(4):220-236. PubMed ID: 28514781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron Balance and the Role of Hepcidin in Chronic Kidney Disease.
    Ganz T; Nemeth E
    Semin Nephrol; 2016 Mar; 36(2):87-93. PubMed ID: 27236128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status of iron metabolism: Clinical and therapeutic implications.
    Conde Diez S; de Las Cuevas Allende R; Conde García E
    Med Clin (Barc); 2017 Mar; 148(5):218-224. PubMed ID: 28073521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron disorders and hepcidin.
    Rana S; Prabhakar N
    Clin Chim Acta; 2021 Dec; 523():454-468. PubMed ID: 34755647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Manipulation of the hepcidin pathway for therapeutic purposes.
    Fung E; Nemeth E
    Haematologica; 2013 Nov; 98(11):1667-76. PubMed ID: 24186312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepcidin as a biochemical parameter for the assessment of iron deficiency anemia.
    Lemos Ados R; Ismael LA; Boato CC; Borges MT; Rondó PH
    Rev Assoc Med Bras (1992); 2010; 56(5):596-9. PubMed ID: 21152835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepcidin, an overview of biochemical and clinical properties.
    Rauf A; Shariati MA; Khalil AA; Bawazeer S; Heydari M; Plygun S; Laishevtcev A; Hussain MB; Alhumaydhi FA; Aljohani ASM
    Steroids; 2020 Aug; 160():108661. PubMed ID: 32450084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepcidin and its potential clinical utility.
    Miseta A; Nagy J; Nagy T; Poór VS; Fekete Z; Sipos K
    Cell Biol Int; 2015 Nov; 39(11):1191-202. PubMed ID: 26109250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepcidin as a biomarker for the diagnosis of iron metabolism disorders: a review.
    Vermeulen E; Vermeersch P
    Acta Clin Belg; 2012; 67(3):190-7. PubMed ID: 22897067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepcidin: clinical utility as a diagnostic tool and therapeutic target.
    Coyne DW
    Kidney Int; 2011 Aug; 80(3):240-4. PubMed ID: 21677632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepcidin: A key regulator of iron.
    Saneela S; Iqbal R; Raza A; Qamar MF
    J Pak Med Assoc; 2019 Aug; 69(8):1170-1175. PubMed ID: 31431773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hepcidin as a central mediator of anemia of chronic diseases associated with obesity].
    Villarroel H P; Arredondo O M; Olivares G M
    Rev Med Chil; 2013 Jul; 141(7):887-94. PubMed ID: 24356737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepcidin in chronic kidney disease: not an anaemia management tool, but promising as a cardiovascular biomarker.
    van der Weerd NC; Grooteman MP; Nubé MJ; ter Wee PM; Swinkels DW; Gaillard CA
    Neth J Med; 2015 Mar; 73(3):108-18. PubMed ID: 25852110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of The Canidae Iron Regulatory Hormone Hepcidin.
    Mead MK; Claus M; Litton E; Smart L; Raisis A; Rossi G; Trengove RD; Gummer JPA
    Sci Rep; 2019 Dec; 9(1):19400. PubMed ID: 31852911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Iron-refractory iron deficiency anemia].
    Kawabata H
    Rinsho Ketsueki; 2016 Feb; 57(2):104-9. PubMed ID: 26935626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of iron deficiency diagnosis using hepcidin mass spectrometry dosage methods on hospital stay and costs after a prolonged ICU stay: Study protocol for a multicentre, randomised, single-blinded medico-economic trial.
    Lasocki S; Puy H; Mercier G; Lehmann S;
    Anaesth Crit Care Pain Med; 2017 Dec; 36(6):391-396. PubMed ID: 28919067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-depth review: is hepcidin a marker for the heart and the kidney?
    Afsar RE; Kanbay M; Ibis A; Afsar B
    Mol Cell Biochem; 2021 Sep; 476(9):3365-3381. PubMed ID: 33942218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.